Pretreatment of Shaoyao Gancao Decoction () alters pharmacokinetics of intravenous paclitaxel in rats.
OBJECTIVE
To investigate the effect of Shaoyao Gancao Decoction (, SGD) on the pharmacokinetics of intravenously administered paclitaxel in rats.


METHODS
Paclitaxel was intravenously administered to rats (3 mg/kg) with or without the concomitant administration of SGD (752 mg/kg, a single day or 14 consecutive days pretreatment). The paclitaxel in the serum was quantified using a simple and rapid ultra performance liquid chromatography (UPLC) method for the pharmacokinetic study. The pharmacokinetic parameters were calculated via a non-compartment model using the computer program DAS 2.0.


RESULTS
The pharmacokinetic parameters of paclitaxel were significantly altered in response to 14 consecutive days of pretreatment with SGD. The area under the curve (AUC0-t, from 4 820±197 to 4 205±186 ng·mL-1·-1) and AUC0-∞(from 5 237±280 to 4 514±210 ng·mL-1·-1) significantly decreased in response to the 14-day pretreatment with SGD. The values of Vdss(L/kg) were 10.74±1.08 and 9.35±0.49, those of CL (L/kg) were 0.67±0.03 and 0.57±0.03 and the t1/2(h) values were 11.17±0.84 and 11.32±0.93, respectively, for the 14-day SGD pretreatment and intravenous paclitaxel alone. The AUC0-tand AUC0-∞values decreased by 13% and 14% (P<0.01), respectively. The area under the curve decreased signifificantly (P<0.01), and the total clearance increased by 1.2-fold (P<0.01), after 14 consecutive days of pretreatment with SGD. A single-day pretreatment with SGD did not signifificantly affect the pharmacokinetic parameters of paclitaxel.


CONCLUSIONS
SGD administration for 14 consecutive days increased the metabolism of paclitaxel, while a 1-day pretreatment had little effect. The results would contribute important information to the study on interaction between Chinese medicines and chemotherapy and also help to utilize SGD better in the adjunctive therapy of cancer patients.
Laboratory of Ethnopharmacology, Institute of Integrated Traditional Medicine and Western Medicine, Xiangya Hospital, Central South University, Changsha, 410008, China.
Yang
Y
Wang
Laboratory of Ethnopharmacology, Institute of Integrated Traditional Medicine and Western Medicine, Xiangya Hospital, Central South University, Changsha, 410008, China.
Xi
X
Huang
Department of Oncology, Xiangya Hospital, Central South University, Changsha, 410008, China.
Mei-Zuo
MZ
Zhong
Department of Stomatology, the Third Xiangya Hospital, Central South University, Changsha, 410008, China.
Ruo-Huang
RH
Lu
Laboratory of Ethnopharmacology, Institute of Integrated Traditional Medicine and Western Medicine, Xiangya Hospital, Central South University, Changsha, 410008, China.
Zi-An
ZA
Xia
Laboratory of Ethnopharmacology, Institute of Integrated Traditional Medicine and Western Medicine, Xiangya Hospital, Central South University, Changsha, 410008, China.
Rong
R
Fan
Department of geriatrics, Xiangya Hospital, Central South University, Changsha, 410008, China.
Bo
B
Liu
Laboratory of Ethnopharmacology, Institute of Integrated Traditional Medicine and Western Medicine, Xiangya Hospital, Central South University, Changsha, 410008, China.
Wei
W
Huang
Department of Oncology, Xiangya Hospital, Central South University, Changsha, 410008, China. ganppxy@aliyun.com.
Ping-Ping
PP
Gan
D000818:Animals; D002851:Chromatography, High Pressure Liquid; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage* / Q000627:therapeutic use*; D007275:Injections, Intravenous; D008297:Male; D017239:Paclitaxel / Q000008:administration & dosage* / Q000097:blood / Q000737:chemistry / Q000493:pharmacokinetics*; D017207:Rats, Sprague-Dawley; D012015:Reference Standards; D013997:Time Factors
D004365:Drugs, Chinese Herbal; C499903:jackyakamcho-tang; D017239:Paclitaxel
Shaoyao Gancao Decoction; drug interactions; paclitaxel; pharmacokinetic
Asia Pac J Clin Nutr. 2008;17(1):17-22
18364321
Cancer Chemother Pharmacol. 2005 Sep;56(3):248-54
15856231
Pain. 2001 Dec;94(3):293-304
11731066
J Pharm Pharm Sci. 2002 May-Aug;5(2):185-9
12207872
Support Care Cancer. 2009 Mar;17(3):315-20
18839222
Planta Med. 2012 Feb;78(3):237-43
22161762
Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(19):2710-4
22242435
Toxicol Appl Pharmacol. 2005 Dec 15;209(3):263-8
15936791
Evid Based Complement Alternat Med. 2012;2012:751046
22778776
J Clin Oncol. 2003 Aug 1;21(15):2810-4
12807932
Front Med. 2011 Jun;5(2):127-33
21695616
Clin Pharmacol Ther. 2004 Oct;76(4):323-9
15470331
Phytother Res. 2009 May;23(5):603-7
19173278
Support Care Cancer. 2004 Sep;12(9):619-25
15258838
Oncologist. 2006 Jul-Aug;11(7):742-52
16880233
J Pharm Biomed Anal. 2005 Sep 1;39(1-2):170-6
16085137
JAMA. 2003 Sep 17;290(11):1500-4
13129991
Support Care Cancer. 2004 Jun;12(6):454-62
14991387
Cancer Res. 1994 Aug 1;54(15):4026-35
7913410
Phytother Res. 2006 Dec;20(12):1046-51
17006975
Gan To Kagaku Ryoho. 2004 Oct;31(10):1537-40
15508446
Pain. 2006 Jun;122(3):245-57
16530964
Life Sci. 2006 Mar 27;78(18):2131-45
16442130
Gynecol Oncol. 2001 May;81(2):333-4
11330975
Eur J Pain. 2009 Jan;13(1):22-7
18472288
J Pharmacol Exp Ther. 2006 Mar;316(3):1369-77
16267138
Br J Clin Pharmacol. 2007 Mar;63(3):258-67
17116126